PHARMACOSMOS SUCCESFULLY REGISTERS DEXTRAN 40 AND 70 AS EXCIPIENTS IN CHINA
REGISTRATIONS ARE PUBLICED BY CHINA FDA (CFDA)
Dextran 40 EP, reference number F20190000213
Dextran 70 EP, reference number F20190000214
Pharmacosmos, a world leader in developing and producing carbohydrates for pharmaceutical applications, has registered Pharmaceutical Quality Dextran 40 EP Monograph and Dextran 70 EP Monograph as excipients in China. The registrations are published on the CFDA website and can be referenced through a letter of access when the Dextran is used as excipients in final products.
Pharmaceutical Quality Dextran 40 EP and 70 EP are available from Pharmacosmos as excipients for final formulations, drug products, for medical devices, for production of solutions for injection and infusion and much more.
Pharmacosmos is the only Dextran Manufacturer that has received Certificates from the US FDA and the European Directorate for the Quality of Medicines (EDQM) for the Specific Pharmacopoeial Dextran 40 and 70.
For additional information on how to obtain a letter of access to the new excipient registration or about the Dextran products, please contact us on dextran@pharmacosmos.com
Anne-Marie J. Ørkild
Director, International Sales and Business Carbohydrates
Phone: +45 5948 5959
E-mail: dextran@pharmacosmos.com
Pharmacosmos is the only dextran manufacturer holding certificates from the US FDA and European Directorate for the Quality of Medicines (EDQM)
Pharmacosmos delivers a unique dextran quality through a production technology that completely avoids the use of organic solvents and a quality system that meets the strictest cGMP standards for human medicines
Pharmacosmos sells and ships directly to clients everywhere in the World. We deliver Pharmaceutical Quality Dextran of the highest standards, including those of the European Pharmacopoeia (EP), the United States Pharmacopoeia (USP), and the Japanese Pharmacopoeia (JP).